Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001842952-23-000043
Filing Date
2023-03-22
Accepted
2023-03-22 17:22:37
Documents
6
Effectiveness Date
2023-03-22

Document Format Files

Seq Description Document Type Size
1 S-8 cntxs-82023.htm S-8 51335
2 EX-FILING FEES cntx-formsx82023evergreenx.htm EX-FILING FEES 17937
3 EX-5.1 cntx-ex51opinionforformsx8.htm EX-5.1 11619
4 EX-23.1 a231cohnreznicks-8consent.htm EX-23.1 2908
5 image_0a.jpg GRAPHIC 90
6 picture1.jpg GRAPHIC 6731
  Complete submission text file 0001842952-23-000043.txt   94525
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270759 | Film No.: 23753768
SIC: 2834 Pharmaceutical Preparations